Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Zevra Therapeutics, Inc. (ZVRA) had Pre-Tax Profit Margin of 123.70% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$36.22M |
|
$36.32M |
|
$1.90M |
|
$34.32M |
|
$-15.93M |
|
$52.15M |
|
$-7.34M |
|
$44.80M |
|
$44.80M |
|
$37.89M |
|
$37.89M |
|
$37.89M |
|
$37.89M |
|
$52.15M |
|
$51.89M |
|
58.41M |
|
60.23M |
|
$0.62 |
|
$0.60 |
|
| Balance Sheet Financials | |
$229.97M |
|
$0.43M |
|
$48.61M |
|
$278.58M |
|
$47.03M |
|
-- |
|
$25.75M |
|
$72.78M |
|
$205.80M |
|
$195.00M |
|
$205.80M |
|
59.12M |
|
| Cash Flow Statement Financials | |
$6.14M |
|
$79.62M |
|
$-52.80M |
|
$62.41M |
|
$95.59M |
|
$33.19M |
|
$3.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
94.76% |
|
143.97% |
|
143.97% |
|
-- |
|
|
Pre-Tax Profit Margin |
123.70% |
100.27% |
|
$6.15M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.82 |
|
1.64 |
|
54.91 |
|
18.41% |
|
19.43% |
|
13.60% |
|
18.41% |
|
$3.48 |
|
$0.10 |
|
$0.10 |
|